CITIC Bank: Redemption of open-ended capital bonds. CITIC Bank announced that from December 9 to December 11, 2019, it issued RMB 40 billion of open-ended capital bonds (hereinafter referred to as "current bonds"), and on December 12, 2019, it issued the Announcement of China CITIC Bank Corporation on the Completion of Issuance of Open-ended Capital Bonds. According to the relevant provisions of the prospectus of this issue, this issue has the issuer's conditional redemption right, and the issuer has the right to redeem this issue in whole or in part on the interest payment date of the fifth year of this issue, that is, December 11, 2024. As of the date of this announcement, with the approval of the State Financial Supervision and Administration, the Bank has exercised the right of redemption and redeemed the bonds in full.Kremlin: Actions in the Golan Heights and the buffer zone are unlikely to help stabilize the situation in Syria.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)
Chilean Mining Association (SONAMI): Copper production in Chile is affected by poor project performance.Diplomat: The EU envoy failed to reach an agreement on the 15th round of sanctions against Russia.Luo Xingfa, former party secretary and president of Guangyuan Radio and TV University and former president of Guangyuan Cadre Network College, was investigated. Luo Xingfa, former party secretary and president of Guangyuan Radio and TV University and former president of Guangyuan Cadre Network College, was suspected of serious violation of the law and is currently under disciplinary review and supervision investigation by the Supervision Committee of Guangyuan Municipal Commission for Discipline Inspection.
The Israeli army demanded that some residents in central Gaza be evacuated to the "humanitarian zone". On the 11th local time, Avikai Adrahi, Arabic spokesperson of the Israel Defense Forces, issued a warning on social media, demanding that some residents in the central Gaza Strip be evacuated immediately and transferred to the so-called "humanitarian zone".The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)The minimum acceptable price of the two-year national debt issued by the Ministry of Finance in Hong Kong is 100.62 yuan. The minimum acceptable price of the five-year national debt issued by the Ministry of Finance in Hong Kong is 102.41 yuan.
Strategy guide 12-14
Strategy guide
12-14